CymitQuimica logo

Ac-QVPLRPMTYK-NH2

Ref. 3D-PP43476

ne
To inquire
Ac-QVPLRPMTYK-NH2
Biosynth

Product Information

Name:Ac-QVPLRPMTYK-NH2
Synonyms:
  • Ac-Gln-Val-Pro-Leu-Arg-Pro-Met-Thr-Tyr-Lys-amide
Brand:Biosynth
Description:Peptide Ac-QVPLRPMTYK-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-QVPLRPMTYK-NH2 include the following: Binding and transport of melanoma-specific antigenic peptides by the transporter associated with antigen processing SA Chang, VG Lacaille, DS Guttoh - Molecular immunology, 1996 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S016158909600082X Identification of HLA-A11-Restricted HIV-1-Specific Cytotoxic Tlymphocyte Epitopes in China S Wang, Y Sun, S Zhai, Y Zhuang, S Zhao - Current HIV , 2007 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/chr/2007/00000005/00000001/art00012 Apparent Lack of BRAFV600E Derived HLA Class I Presented Neoantigens Hampers Neoplastic Cell Targeting by CD8+ T Cells in Langerhans Cell Histiocytosis PG Kemps , TC Zondag, EC Steenwijk - Frontiers in , 2020 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2019.03045/full Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides. M DiBrino, KC Parker, J Shiloach - Proceedings of the , 1993 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.90.4.1508 Structures of HLA-A* 1101 complexed with immunodominant nonamer and decamer HIV-1 epitopes clearly reveal the presence of a middle, secondary anchor L Li, M Bouvier - The Journal of Immunology, 2004 - journals.aai.orghttps://journals.aai.org/jimmunol/article/172/10/6175/36282 Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100. JC Skipper, DJ Kittlesen, RC Hendrickson - (Baltimore, Md.: 1950 , 1996 - journals.aai.orghttps://journals.aai.org/jimmunol/article-abstract/157/11/5027/29438 Flow-cytometric determination of peptide-class I complex formation identification of p53 peptides that bind to HLA-A2 HJ Zeh III , GH Leder, MT Lotze, RD Salter, M Tector - Human immunology, 1994 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0198885994901058 An HLA-A* 11: 01-binding neoantigen from mutated NPM1 as target for TCR gene therapy in AML DI van der Lee, G Koutsoumpli, RM Reijmers - Cancers, 2021 - mdpi.comhttps://www.mdpi.com/2072-6694/13/21/5390 The Use of Epstein-Barr Virus-Transformed B Lymphocyte Cell Lines in a Peptide-Reconstitution Assay: Identification of CEA-Related HLA-A* 0301-Restricted AJA Bremers, SH van der Burg - Journal of , 1995 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/abstract/1995/08000/The_Use_of_Epstein_Barr_Virus_Transformed_B.1.aspx
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Technical inquiry about: Ac-QVPLRPMTYK-NH2

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.